<?xml version="1.0" encoding="UTF-8"?>
<fig id="ppat.1006932.g002" orientation="portrait" position="float">
 <object-id pub-id-type="doi">10.1371/journal.ppat.1006932.g002</object-id>
 <label>Fig 2</label>
 <caption>
  <title>Mechanisms of Ebola virus (EBOV) interaction with T cells.</title>
  <p>(A) Role of Toll-Like Receptor 4 (TLR-4) and T-cell immunoglobulin-like protein 1 (Tim-1) in binding of EBOV to T cells. (B) Induction of TLR-4 signaling by EBOV and effects of Eritoran. Summarized from references [
   <xref rid="ppat.1006932.ref017" ref-type="bibr">17</xref>, 
   <xref rid="ppat.1006932.ref027" ref-type="bibr">27</xref>, 
   <xref rid="ppat.1006932.ref028" ref-type="bibr">28</xref>]. PS, phosphatidylserine; TCR, T cell receptor; GP, glycoprotein; DC, dendritic cell; Myd88, myeloid differentiation primary receptor response 88; IRAK-1, -2, -4, interleukin-1 receptor-associated kinase 2, 3, 4; TRAF-3, -6, TNF Receptor Associated Factor 3, 6; TAB-2, -3, TGF-beta-activated kinase 1/MAP3K7 Binding Protein 2; TAK1, transforming growth factor beta activated kinase 1 (MAP3K7); p38, mitogen-activated protein kinase; IKKα, -β, -ε, inhibitor of nuclear factor kappa kinase; NFκB, nuclear factor kappa-light-chain-enhancer of activated B cells; RIP1, receptor-interacting protein 1; TRAM1, translocation associated membrane protein 1; TBK1, TANK binding kinase 1; IRF3, interferon regulatory factor 3; IFNα, -β, interferon α, -β.
  </p>
 </caption>
 <graphic xlink:href="ppat.1006932.g002" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
